PCI Biotech Holding ASA (OSL:PCIB) EV-to-EBITDA : -2.32 (As of Jun. 18, 2025)

PCI Biotech Holding ASA EV-to-EBITDA Chart

PCI Biotech Holding ASA Annual Data
	Trend	Dec15	Dec16	Dec17	Dec18	Dec19	Dec20	Dec21	Dec22	Dec23	Dec24
EV-to-EBITDA		Get a 7-Day Free Trial					-12.28	-4.73	-0.44	-1.91	-1.12

PCI Biotech Holding ASA Semi-Annual Data
	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
EV-to-EBITDA	Get a 7-Day Free Trial															-0.44	-1.13	-1.91	-	-1.12

Competitive Comparison of PCI Biotech Holding ASA's EV-to-EBITDA

For the Biotechnology subindustry, PCI Biotech Holding ASA's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

PCI Biotech Holding ASA's EV-to-EBITDA Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, PCI Biotech Holding ASA's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where PCI Biotech Holding ASA's EV-to-EBITDA falls into.

PCI Biotech Holding ASA EV-to-EBITDA Calculation

PCI Biotech Holding ASA's EV-to-EBITDA for today is calculated as:

PCI Biotech Holding ASA's current Enterprise Value is kr37.10 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. PCI Biotech Holding ASA's EBITDA for the trailing twelve months (TTM) ended in Dec. 2024 was kr-16.02 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PCI Biotech Holding ASA  (OSL:PCIB) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

PCI Biotech Holding ASA's PE Ratio (TTM) for today is calculated as:

PCI Biotech Holding ASA's share price for today is kr1.70.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. PCI Biotech Holding ASA's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2024 was kr-0.438.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).

Please read Which price ratio outperforms the enterprise multiple?

PCI Biotech Holding ASA EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of PCI Biotech Holding ASA's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.

PCI Biotech Holding ASA Business Description